This activity has expired.

Caring for Outliers in a Mean Minded World: Healthcare Reform and Its Implications for Pain Management

Release Date: January 24, 2014
Expiration Date: February 16, 2015

Intended Audience

Physicians, registered nurses and physician assistants

Learning Objectives

Upon completion of this activity, the participant should be able to:

  • Describe current models of health care and the obstacles/opportunities they pose for high-quality, effective individualized pain care.
  • Explore implications of framing pain as a public health (population-based) concern in an era of personalized, "precision" medicine.
  • Describe tension between traditional, RCT- and MA-based EBM and emerging PBE.
  • Convey optimism that support for activities to relieve pain will continue as care becomes more patient-centered.

Statement of Need

The culture of medicine in the US has gravitated towards common denominators and utilitarian approaches.  This prominent mind-set has worked to the exclusion of effective, personalized treatment of patients who's medical needs do not fit within the guise of "average" treatment for the condition.  The United States is among the highest healthcare -spending nations per capita and yet our primary care score is among the lowest.  This approach to medicine has failed our "outlying" patients and is detrimental to our healthcare system as a whole and should be re-evaluated by healthcare professionals.  

Method of Participation

This activity should take approximately one hour to complete. Participants should first read the objectives and other introductory CME/CE information and then proceed to the educational activity. To receive credit for this activity, participants must complete the post-test with a passing score of 80% and then complete the evaluation. Credit is provided through January 24, 2015. No credit will be given after this date. There is no fee to participate in this activity.

In the event you have questions about this activity or are unable to retrieve the certificate, please email cme@dannemiller.com and a certificate will be emailed within 2 weeks.

System requirements

  • Computer, tablet, or smart phone with internet access
  • Web browser (IE 8.0+ or Webkit/Mozilla Compatible) with Javascript enabled
  • HTML5 compatible browser or Adobe Flash Player

Accreditation

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Dannemiller and the Journal of Opioid Management.  Dannemiller is accredited by the ACCME to provide continuing medical education for physicians.

Physicians

Dannemiller designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Registered Nurses

Dannemiller is a provider approved by the California Board of Registered Nursing, Provider Number 4229 for 1.00 contact hours. CBRN credit is not accepted by the Michigan and Utah State licensing boards.

Physician Assistants

AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Physician assistants may receive a maximum of 1.00 AMA PRA Category 1 Credit(s)™ for completing this program.

Faculty

Daniel B. Carr, MD
Tufts University School of Medicine

Disclosures

In accordance with the Accreditation Council for Continuing Medical Education (ACCME), Dannemiller requires that any person who is in a position to control the content of a CME activity must disclose all relevant financial relationships they have with a commercial interest.

The following individuals stated they have no relevant financial disclosure:

  • Daniel B. Carr, MD (Faculty)
  • Richard A. DeVito Jr. (JOM, non-faculty planner)
  • Michael Glynn (JOM, non-faculty planner)

Bernard Abrams, MD, content reviewer and Ashley Amerson, Dannemiller project manager have no financial relationships with commercial interests.

To resolve identified/potential conflicts of interest, the educational content was fully reviewed by a member of the Dannemiller Clinical Content Review Committee who has nothing to disclose. The resulting certified activity was found to provide educational content that is current, evidence based and commercially balanced.

Off-label statement

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.

Disclaimer

The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Dannemiller or the Journal of Opioid Management. This material is prepared based upon a review of multiple sources of information, but it is not exhaustive of the subject matter. Therefore, healthcare professionals and other individuals should review and consider other publications and materials on the subject matter before relying solely upon the information contained within this educational activity.